DEF: HCA Healthcare Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals

HCA Healthcare will hold its annual meeting of stockholders on April 24, 2025, in a virtual format, to vote on director elections, executive compensation, and several stockholder proposals.

Summary

• HCA Healthcare will conduct its annual meeting of stockholders virtually on April 24, 2025, at 2:00 p.m. (CDT).
• Stockholders of record as of February 24, 2025, are eligible to vote.
• The meeting agenda includes the election of nine director nominees, ratification of Ernst & Young LLP as the independent accounting firm, and an advisory vote on executive compensation.
• Stockholders will also vote on amendments to the 2020 Stock Incentive Plan, the company's certificate of incorporation, and several stockholder proposals.
• The board recommends voting for the director nominees, ratifying the accounting firm, approving executive compensation and the incentive plan amendment, and approving the certificate of incorporation amendment.
• The board recommends voting against the stockholder proposals regarding golden parachutes, the Patient Safety Committee charter, and the acquisition strategy report.
• The proxy statement and 2024 annual report are available online at www.hcahealthcare.com.

Sentiment

Score: 7

Explanation: The document is primarily factual and informative, with a positive outlook on the company's performance and governance. However, there are some negative aspects mentioned, such as the board's recommendation to vote against certain stockholder proposals and a late filing of a Form 4.

Positives

• The board is committed to strong corporate governance practices.
• The company has a proxy access right for stockholders.
• The board oversees enterprise-wide risk management processes.
• The company discloses political contributions and public advocacy efforts.
• The company engages with stockholders throughout the year.
• The company has a code of ethics applicable to all directors, officers, and employees.

Negatives

• The board recommends voting against stockholder proposals regarding lavish golden parachutes, amendment to the Patient Safety and Quality of Care Committee charter, and a report on acquisition strategy.
• One Form 4 was filed late for Jon M. Foster due to administrative error.

Risks

• Forward-looking statements are subject to uncertainties and risks discussed in the 2024 Annual Report on Form 10-K and subsequent SEC filings.
• The company faces cybersecurity risks and is actively reviewing and overseeing its data security programs.
• The company's ability to attract and retain executive talent could be hindered by the stockholder proposal regarding golden parachutes.

Future Outlook

The company plans to continue to examine its corporate governance policies and leadership structure on an ongoing basis to ensure that they continue to meet the company's needs.

Management Comments

• The Company's mission statement guides everything we do, including our dedication to being a responsible citizen in our communities.
• At HCA Healthcare, we believe excellent people make excellence happen.
• The Board believes that this leadership structure improves the Boards ability to focus on key policy and operational issues, including with respect to risk oversight, and helps the Company operate in the long-term interests of stockholders.

Industry Context

The document provides insights into HCA Healthcare's governance, compensation practices, and strategic priorities, offering a view into how the company positions itself within the broader healthcare services industry.

Comparison to Industry Standards

• The company benchmarks executive compensation against a peer group of large public healthcare companies, including Abbott Laboratories, Amgen Inc., Bristol-Myers Squibb Company, Cardinal Health, Inc., Cencora, Inc., Centene Corp., Community Health Systems, Inc., Elevance Health, Inc., Eli Lilly and Company, Humana Inc., Johnson & Johnson, Medtronic Inc., Merck & Co., Inc., Pfizer Inc., Tenet Healthcare Corporation, The Cigna Group, Thermo Fisher Scientific Inc., UnitedHealth Group Incorporated, and Universal Health Services, Inc.
• The company's performance scores on the Centers for Medicare & Medicaid Services (CMS) inpatient and outpatient measures continued to exceed the CMS national averages.
• 49 of HCA Healthcares hospitals were named on the 2025 Healthgrades Americas 250 Best Hospitals list, which recognizes the top 5% of hospitals in the country for clinical excellence.

Management Changes

Corporate Governance

Related Party Transactions

• The company has a Stockholders Agreement with Hercules Holding II and the Investors, which provides for certain rights of the Frist Entities to nominate two members of our Board of Directors.
• Hercules Holding and the Investors have entered into a registration rights agreement with HCA Healthcare, Inc. Pursuant to this agreement, the Investors who still hold shares of our common stock directly or through Hercules Holding can cause us to register those shares under the Securities Act and, if requested, to maintain a shelf registration statement effective with respect to such shares.
• Pursuant to a management stockholders agreement we entered into with certain members of senior management, following our IPO, certain members of senior management, including certain executive officers, have limited piggyback registration rights with respect to certain of their shares of common stock.

Stakeholder Impact

• The company's operations make it a major contributor to local economies and help create healthier tomorrows for those who live in the communities we serve.
• HCA Healthcare employs approximately 316,000 colleagues and paid combined payroll and benefits of more than $31 billion in 2024.
• In 2024, HCA Healthcare provided uncompensated care at an estimated cost of approximately $4.4 billion, and we spent $4.9 billion in capital investment.
• In 2024, we provided more than $48.5 million in enterprise giving to community organizations and $18 million in colleague giving with HCA Healthcare matching contributions.

Next Steps

• Stockholders should vote on the proposals outlined in the proxy statement.
• The company will file a Current Report on Form 8-K with the SEC following the annual meeting to announce the final voting results.

Key Dates